Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🥇 First rule of investing? Know when to save! Up to 55% off before BLACK FRIDAY
Get Early Bird Access
Search Results for "PBYI":
Results: 281
News
Puma Biotechnology earnings beat by $0.06, revenue fell short of estimates
By Investing.com
Investing.com - Puma Biotechnology (NASDAQ: PBYI) reported third quarter EPS of $0.150, $0.06 better than the analyst estimate of $0.090. Revenue for the quarter came in at $55.1M versus the consensus...
Puma Bio's Nerlynx in treatment guidelines for certain breast cancer patients
By Seeking Alpha
Puma Biotechnology (PBYI -0.7%) announces that NERLYNX (neratinib) is now included in the National Comprehensive Central Network (NCCN) Clinical Practice Guidelines in breast cancer patients with...
Briefing docs out for Ad Comm review of Puma's neratinib; shares up 52%
By Seeking Alpha
Puma Biotechnology (PBYI +51.5%) rockets on average volume after the release of the briefing materials for Wednesday's FDA advisory committee review of its New Drug Application (NDA) seeking approval...
Analysis
Puma Biotechnology (PBYI): Moving Average Crossover Alert
By Zacks Investment Research
Are you a technical investor? If so, it may be time to consider Puma Biotechnology, Inc. (NYSE:PBYI) for your portfolio. The company just saw its 50 Day Moving Average breakout above its 200 Day...
Puma (PBYI) Presents Favorable Phase II Data On Neratinib
By Zacks Investment Research
Puma Biotechnology, Inc. (NYSE:ANIP) and Retrophin, Inc. (NASDAQ:RTRX) , each sporting a Zacks Rank #1 (Strong Buy). ASTRAZENECA PLC (AZN): Free Stock Analysis Report RETROPHIN INC (RTRX): Free...
Puma (PBYI) Stock Up, Phase II Data On Neratinib Published
By Zacks Investment Research
Puma Biotechnology, Inc. (NYSE:INVA) and Pfizer Inc. (NYSE:PFE) . While Innoviva sports a Zacks Rank #1 (Strong Buy), Pfizer carries a Zacks Rank #2 (Buy). ROCHE HLDG LTD (RHHBY): Free Stock...
Results: 1
Refine Results
Instrument Type
Region
Sector
Industry
- All Industries
- Coal
- Oil & Gas
- Oil & Gas Related Equipment and Services
- Renewable Energy
- Uranium
- Chemicals
- Metals & Mining
- Construction Materials
- Paper & Forest Products
- Containers & Packaging
- Aerospace & Defense
- Machinery, Tools, Heavy Vehicles, Trains & Ships
- Construction & Engineering
- Diversified Industrial Goods Wholesale
- Professional & Commercial Services
- Freight & Logistics Services
- Passenger Transportation Services
- Transport Infrastructure
- Automobiles & Auto Parts
- Textiles & Apparel
- Homebuilding & Construction Supplies
- Household Goods
- Leisure Products
- Hotels & Entertainment Services
- Media & Publishing
- Diversified Retail
- Specialty Retailers
- Beverages
- Food & Tobacco
- Personal & Household Products & Services
- Food & Drug Retailing
- Consumer Goods Conglomerates
- Banking Services
- Investment Banking & Investment Services
- Insurance
- Collective Investments
- Investment Holding Companies
- Healthcare Equipment & Supplies
- Healthcare Providers & Services
- Pharmaceuticals
- Biotechnology & Medical Research
- Semiconductors & Semiconductor Equipment
- Communications & Networking
- Electronic Equipment & Parts
- Office Equipment
- Computers, Phones & Household Electronics
- Integrated Hardware & Software
- Software & IT Services
- Financial Technology (Fintech) & Infrastructure
- Telecommunications Services
- Electrical Utilities & IPPs
- Natural Gas Utilities
- Water & Related Utilities
- Multiline Utilities
- Real Estate Operations
- Residential & Commercial REITs
- Institutions, Associations & Organizations
- Government Activity
- Miscellaneous Educational Service Providers
- School, College & University
- Professional & Business Education
Quotes
Results: 146
Refine Results
Date
Date
Category
Provider
- All Providers
- Reuters
- Investing.com DNA 3rd party news
- Investing.com
- International Business Times
- Yahoo Finance
- FinanceMagnates
- Financial Times
- Forbes
- Bloomberg_video
- Business Insider
- Seeking Alpha
- Financial news 24
- Bloomberg
- DC Forecasts
- Cryptovest
- Cointelegraph
- AMBCrypto
- CoinDesk
- Crypto Globe
- blokt
- test
- The Conversation
- Allrates
- Money Show
- Euronews
- RealVision
- bizportal
- FX Street
- FX Empire
- Investing.com
- Investing.com
- Investing.com
- Crunchbase
- CoinEdition
- DailyCoin
- StockNews
- U.Today
- Investing.com
- Crypto.news
- Investing.com
- Quiver Quantitative
- Stock Story
- Chainwire
- CME Group
- Yolowire.com
- Bitcoin World
- FinanceWire
- TEST
- PR Desk
- PulseBulletin.com
- Pinion Newswire
- Live Bitcoin News
- Bitwire
- Press Desk
- Coinzilla
- TechnologyWire
- Investing.com RSS CTA
News
Please try another search
Results: 134
Analysis
Results: 0
Tools & Sections
Results: 0
Authors
- Sign up for FREE and get:
- Real-Time Alerts
- Advanced Portfolio Features
- Personalized Charts
- Fully-Synced App